http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190124950-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fd15d8ebb22202b5cfe2b109cd922c5 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4995 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4995 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2018-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_573cc7aa025ec05a0fa4261f33a8b2c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a6eae7adc9d07dab60f6bfedea5f9e1 |
publicationDate | 2019-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20190124950-A |
titleOfInvention | Compositions for preventing or treating lung cancer or colon cancer comprising PFI-3 |
abstract | The present invention relates to a composition for the prevention or treatment of lung cancer or colorectal cancer comprising PFI-3, specifically comprising a composition for the treatment of lung cancer or colorectal cancer, including PFI-3 or a pharmaceutically acceptable salt thereof; Pharmaceutical compositions for the prevention or treatment of lung cancer or colorectal cancer; And it relates to a composition for enhancing sensitivity to the treatment of lung cancer or colorectal cancer. PFI-3 of the present invention has an effect of improving the survival rate of lung cancer or colorectal cancer cells as well as the anticancer agent or radiation sensitivity of the cancer cells, it can be usefully used for the prevention, improvement, treatment of lung cancer or colorectal cancer. |
priorityDate | 2018-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.